Related Experiment Videos
Regulation of self-tolerance by CD80/CD86 interactions
1Department of Immunomodulation, Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121, USA. pinlu@ccmail.bms.com
Current Opinion in Immunology
|March 11, 1998
Summary
Blocking CD80/CD86 costimulation in antigen presentation can inhibit autoimmune diseases. Research using knockout mice clarifies the roles of CD80 and CD86 in T-cell regulation and tolerance induction.
Area of Science:
- Immunology
- Autoimmunity
Background:
- Professional antigen-presenting cells (APCs) expressing CD80/CD86 costimulation induce T-cell activation.
- Insufficient costimulation during antigen presentation may lead to immune tolerance.
- CD80/CD86 blockade inhibits autoimmune disease progression in animal models, but the exact mechanism remains unclear.
Purpose of the Study:
- To clarify the roles of CD80 and CD86 in regulating T-cell activation and tolerance.
- To investigate whether blocking CD80/CD86 restores self-tolerance or merely provides temporary disease blockade in autoimmune conditions.
Main Methods:
- Utilizing data from B7 gene knockout mice.
- Analyzing the effects of CD80/CD86 costimulation on T-cell responses in vivo.
Main Results:
- CD80 and CD86 play crucial roles in T-cell activation and the induction of tolerance.
- The in vivo functions of CD80 and CD86 in autoimmune diseases are complex and influenced by multiple factors.
Conclusions:
- CD80/CD86 costimulation is critical for T-cell activation and immune tolerance.
- Understanding the specific roles of CD80 and CD86 is essential for developing effective therapies for autoimmune diseases.